Status:
RECRUITING
Impact of High Flow Therapy on Complications Related to Airway Stenting
Lead Sponsor:
Cardarelli Hospital
Conditions:
Airway Obstruction
Respiratory Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The application of HFNC therapy in patients with airway stent, improving both humidification and clearance of the airway secretion, could potentially reduce the risk of mucoid impaction, respiratory i...
Eligibility Criteria
Inclusion
- Written informed consent
- Central Airway obstruction, both malignant and nonmalignant, treated with airway stenting (silicone or fully covered metallic stent)
Exclusion
- Contraindication to HFNC (recent - within 3 months - nose surgery or facial trauma)
- Lack of written informed consent
- Neuropsychiatric disorders
- Pregnancy
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06069817
Start Date
January 1 2024
End Date
December 31 2024
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Interventional Pulmonology Unit, Cardarelli Hospital
Napoli, Italy